Transcriptional activation of PPARG in the liver has been shown to induce adipogenic mechanisms to store fatty acids in liver lipid droplets and therefore may be linked to the progression of NAFLD (Lee et al., 2018). The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.